TSHR and Graves disease: (i) Seven patients likely had pre-existing thyroid dysfunction: one patient had overt thyrotoxicosis (TSH <0.01 mIU/L, fT4 51 pmol/L, fT3 15 pmol/L) with positive anti-TPO and anti-Tg, his anti-TSHR titer was elevated at 3.6 IU/L, likely representing co-existing Graves’ disease diagnosed upon admission for acute COVID-19; six patients had subclinical hypothyroidism – three of them positive for anti-TPO.